loading page

Does the power of the laser devices matter for a successful HoLEP procedure? A prospective comparative study
  • +3
  • Zafer Tokatli,
  • Mehmet Ferhat,
  • Muhammed Ibis,
  • Gulcin Turkmen Sariyildiz,
  • Atilla Elhan,
  • Kemal Sarica
Zafer Tokatli
Medicana International Ankara Hospital, Ankara, Turkey
Author Profile
Mehmet Ferhat
Medicana Bah├želievler Hospital, Istanbul, Turkey
Author Profile
Muhammed Ibis
University of Health Sciences, Kecioren Training and Research Hospital, Ankara, Turkey
Author Profile
Gulcin Turkmen Sariyildiz
Medicana Ankara Hospital, Ankara, Turkey
Author Profile
Atilla Elhan
Ankara University School of Medicine, Ankara, Turkey
Author Profile
Kemal Sarica
Biruni University School of Medicine, Istanbul, Turkey
Author Profile

Abstract

Background: To evaluate the efficiency and safety of medium power (MP) holmium laser devices in the enucleation of the enlarged prostate (HoLEP) adenomas compared to high power (HP) laser devices. Methods: Based on the device power used, a total of 120 patients were divided randomly into two groups. While patients in Group 1 were treated with a MP device (50 W) at 39.6-W (2.2J / 18Hz ), patients in Group 2 were treated with HP (100W) device at 42W (1.2J / 35Hz). Peri- and postoperative parameters were well evaluated in both groups with an emphasis on enucleation efficiency and hemoglobin decrease in a comparative manner. Results: Peri- and postoperative parameters as well as functional results were similar in the two groups. The median enucleation efficiency (EE) values in Group 1 and Group 2 were 1.15 (IQR: 0.33-2.2) and 1.11 (IQR: 0.4-2.8), respectively (p=0.775). Hemoglobin decrease values in Group 1 and Group 2 were 1.3 (IQR: 0.1-4) and 1.4 (IQR: 0.4-3.1), respectively (p=0.736). Significant improve in the postoperative functional parameters were noted again in both groups. Conclusion: Our results indicate well that similar to the HP laser devices, effective and safe removal of the enlarged prostate adenomas with MP laser devices (50W) is possible without any technical difficulties, even in patients receiving antithrombotic therapy.

Peer review status:ACCEPTED

05 Apr 2021Submitted to International Journal of Clinical Practice
07 Apr 2021Submission Checks Completed
07 Apr 2021Assigned to Editor
28 Apr 2021Reviewer(s) Assigned
12 May 2021Review(s) Completed, Editorial Evaluation Pending
02 Jun 20211st Revision Received
04 Jun 2021Submission Checks Completed
04 Jun 2021Assigned to Editor
04 Jun 2021Review(s) Completed, Editorial Evaluation Pending
09 Jun 2021Reviewer(s) Assigned
14 Jun 2021Editorial Decision: Accept